Главная Назад


Авторизация
Идентификатор пользователя / читателя
Пароль (для удалённых пользователей)
 

Вид поиска

Область поиска
Найдено в других БД
Формат представления найденных документов:
библиографическое описание краткийполный
Отсортировать найденные документы по:
авторузаглавиюгоду изданиятипу документа
Поисковый запрос: (<.>A=Woosley, Raymond$<.>)
Общее количество найденных документов : 20
Показаны документы с 1 по 20
1.
Woosley Raymond L. Cardiac actions of antihistamines // Annu. Rev. Pharmacol. and Toxicol.. -Palo Alto (Calif.), 1996, Vol. 36.-С.233-252

2.
Determination of clemastine in human plasma by gas chromatography with nitrogen-phosphorus detection // J Chromatgr. B, 2000. Vol. 744, N 1.-С.177-181

3.
Determination of clemastine in human plasma by gas chromatography with nitrogen-phosphorus detection // J Chromatgr. B, 2000. Vol. 744, N 1.-С.177-181

4.
Olanzapine-induced rhabdomyolysis // Ann. Pharmacother., 2001. Vol. 35, N 9.-С.1020-1023

5.
MinK differentially modulates HERG blockade by various neuroleptics // Biophys. J., 2001. Vol. 80, N 1.-С.215-216

6.
Woosley Raymond L. Discovering adverse reactions: Why does it take so long? // Clin. Pharmacol. and Ther., 2004. Vol. 76, N 4.-С.287-289

7.
Woosley Raymond L. Discovering adverse reactions: Why does it take so long? // Clin. Pharmacol. and Ther., 2004. Vol. 76, N 4.-С.287-289

8.
Comparative evaluation of HERG currents and QT intervals following challenge with suspected torsadogenic and nontorsadogenic drugs // J. Pharmacol. and Exp. Ther., 2006. Vol. 316, N 3.-С.1098-1106

9.
Woodcock The FDS critical path initiative and its influence on new drug development // Annual Review of Medicine. Vol.59.2008. -Palo Alto (Calif.), 2008.-С.1-12

10.
The development and testing of intravenous dosing regimens: Application to flecainide for the suppression of ventricular arrhythmias // Clin. Pharmacol. and Ther., 1988. Vol. 43, N 5.-С.499-508

11.
Stereoselective disposition and pharmacologic activity of propafenone enantiomers // Circulation, 1989. Vol. 79, N 5.-С.1068-1076

12.
Woosley Polymorphic drug oxidation: therapeutic implications // Eur. J. Clin. Pharmacol., 1989. Vol. 36, Suppl..-С.6

13.
Mexiletine and tocainide: A comparison of antiarrhythmic efficacy, adverse effestc, and predictive value of lidocaine testing // Clin. Pharmacol. and Ther, 1989. Vol. 45, N 5.-С.553-561

14.
Recainam dose titration and pharmacokinetics in patients with resistant arrhythmias // Clin. Pharmacol. and Ther., 1989. Vol. 46, N 3.-С.324-334

15.
Bajaj Ashok K. Acute electrophysiologic effects of sodium adminisration in dogs treated with O-desmethyl encainide // Circulation, 1989. Vol. 80, N 4.-С.994-1002

16.
Efficacy and safety of ACC-9358, a new antiarrhythmic agent // Amer. J. Cardiol., 1990. Vol. 65, N 13.-С.932-934

17.
Clinical pharmacokinetics of moricizine // Amer. J. Cardiol., 1990. Vol. 65, N 8.-С.21-25

18.
Antiarrhythmic efficacy, clinical elejtrophysiology, and pharmacokinetics of 3-methoxy-O-desmethyl encainide (MODE) in patients with inducible ventricular tachycardia of fibrillation // Circulation, 1989. Vol. 80, N 5.-С.1247-1258

19.
A mechanism of D-(+)-sotalol effects on heart rate not related to 'бета'-adrenoceptor antagonism // Brit. J. Clin. Pharmacol., 1990. Vol. 30, N 2.-С.195-202

20.
Concentration/response relations for the multiple antiarrhythmic actions of sotalol // Amer. J. Cardiol., 1990. Vol. 65, N 2.-С.22-27

 




© Международная Ассоциация пользователей и разработчиков электронных библиотек и новых информационных технологий
(Ассоциация ЭБНИТ)